de-extinction

Colossal Foundation Invests $500K to Restore America’s Largest Tortoise to the Southwest

by | Nov 13, 2025
The Bolson tortoise is North America's largest and rarest tortoise species. Its population has grown from 23 adults to over 800 individuals through captive breeding, with over 150 juveniles released since 2021 showing 80%+ survival rates.
MORE
AGI and De-Extinction: John Carmack and Ben Lamm Join Venture Dallas 2025 Lineup
by | Aug 26, 2025
Set for Oct. 30 at the George W. Bush Presidential Center, this year's Venture Dallas conference will assemble more than 500 entrepreneurs, investors, and business leaders for a day of transformative ideas and connections.
MORE
Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer
by | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE
The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]
Colossal Biosciences Takes On De‑Extinction of New Zealand’s 12‑Foot Moa After Dire Wolf Milestone
by | Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE

Colossal Launches The Colossal Foundation with $50M for ‘BioVault’ Biobanking, Genetic Rescues, and More

by | Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
MORE
Colossal Biosciences Adds Renowned Ancient DNA Expert as Chief Science Officer
by | Mar 19, 2024
Dallas-based Colossal said that in her new role, MacArthur Award winner Beth Shapiro will oversee continued expansion of the company's de-extinction and conservation science teams. The company previously announced plans to "de-extinct" the woolly mammoth, the Tasmanian tiger, and the dodo bird.
MORE
Director of Oscar-Winning ‘My Octopus Teacher’ To Make a Docuseries on Dallas-Based Colossal Biosciences
by | Feb 21, 2024
Colossal Biosciences and production partner Teton Ridge Entertainment have signed with James Reed, director of the Oscar-winning Netflix documentary "My Octopus Teacher," and his company Underdog Films, to produce the docuseries.
MORE

Colossal and Save the Elephants Use Drones and Machine Learning To Track African Elephants

by | Nov 9, 2023
Save the Elephants will deploy a small fleet of drones equipped with high resolution and infrared cameras to capture elephant behavioral data, which will then be processed by Colossal’s machine learning core to develop algorithms that will label elephants and automatically identify individual and collective social behavior.
MORE
Colossal Biosciences, Vertebrate Genomes Project Publish First High-Quality Reference Genome of African Elephant
by | May 19, 2023
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
MORE
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE